Case number 1:17-cv-01481
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 14, 2018 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per entry of D.I. 176 in Lead Civil Action 16-1114-RGA. (nms) |
| May 14, 2018 | 11 | Patent/Trademark Report to Commissioner (1) |
| May 14, 2018 | 11 | Order (3) |
| May 14, 2018 | 11 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,708,371 B2. (Attachments: # (1) Order)(nms) |
| Nov 29, 2017 | 10 | Order (4) Docket Text: SO ORDERED Granting (9 in 17-cv-1481-RGA, 115 in 16-cv-1114-RGA) Stipulation and Order of Consolidation. Signed by Judge Richard G. Andrews on 11/29/2017. Associated Cases: 1:16-cv-01114-RGA, 1:17-cv-01481-RGA(nms) |
| Nov 28, 2017 | 9 | Stipulation (4) Docket Text: STIPULATION and Order of Consolidation by Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC, Ironwood Pharmaceuticals, Inc.. (Noreika, Maryellen) |
| Nov 15, 2017 | 7 | Answer to Complaint (18) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against all Plaintiffs, by Teva Pharmaceuticals USA, Inc..(Keller, Karen) Modified on 11/15/2017 (nms). |
| Nov 15, 2017 | 8 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Oct 25, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (bkb) |
| Oct 25, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Ironwood Pharmaceuticals, Inc.. Teva Pharmaceuticals USA, Inc. served on 10/25/2017, answer due 11/15/2017. (Noreika, Maryellen) |
| Oct 20, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 10/20/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
| Oct 20, 2017 | 1 | Complaint (8) |
| Oct 20, 2017 | 1 | Exhibit A (27) |
| Oct 20, 2017 | 1 | Civil Cover Sheet (1) |
| Oct 20, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Oct 20, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/11/2017. Date of Expiration of Patent: 8/16/2033. Thirty Month Stay Deadline: 2/29/2020. (nmfn) |
| Oct 20, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,708,371 B2. (nmfn) |
| Oct 20, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc for Allergan USA, Inc., Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. No Parents or Affiliates Listed for Ironwood Pharmaceuticals, Inc. (nmfn) |
| Oct 20, 2017 | 1 | Main Document (8) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2248987.) - filed by Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Ironwood Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmfn) |
| Oct 20, 2017 | 1 | Complaint* (1) |
